Ticker Information
Ticker
RPRXCompany Name
ROYALTY PHARMA PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQ$ 827.29MNet Income Common Stock
VS
Market
88
Sector
95
Industry
99
History
59
$ 59.97Close
$ 34.9 - $ 59.9752-Week Range
ROYALTY PHARMA PLC - Net Income Common Stock Chart Analysis (TTM)
Date Range
Zoom
RPRX - Net Income Common Stock Historical Data
| Date | Net Income Common Stock |
|---|---|
| 2026-03-31 | $ 827.29M |
| 2025-12-31 | $ 770.95M |
| 2025-09-30 | $ 764.96M |
| 2025-06-30 | $ 1.02B |
| 2025-03-31 | $ 1.09B |
| 2024-12-31 | $ 858.98M |
| 2024-09-30 | $ 1.15B |
| 2024-06-30 | $ 673.24M |
| 2024-03-31 | $ 798.86M |
| 2023-12-31 | $ 1.13B |
Key Performance Insights, Last 5 Years
- ✓ ROYALTY PHARMA PLC's latest trailing twelve months (TTM) Net Inc. Cmn. stands at $ 827.29M.
- ✓ Over the past 5 years, ROYALTY PHARMA PLC's average Net Inc. Cmn. has been $ 692.55M.
- ✓ The median Net Inc. Cmn. for ROYALTY PHARMA PLC during this period was $ 767.95M
- ✓ ROYALTY PHARMA PLC reached its highest Net Inc. Cmn. over the past 5 years at $ 1.15B.
- ✓ The lowest Net Inc. Cmn. recorded by ROYALTY PHARMA PLC in the same timeframe $ 42.83M
ROYALTY PHARMA PLC's Net Inc. Cmn. vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. Benchmarks
| Company | Net Inc. Cmn. |
|---|---|
| UTHR : UNITED THERAPEUTICS CORP | $ 1.29B |
| MRNA : MODERNA INC | $ -3.19B |
| EXEL : EXELIXIS INC | $ 833.42M |
| NTRA : NATERA INC | $ -226.31M |
| INSM : INSMED INC | $ -1.18B |
| BMRN : BIOMARIN PHARMACEUTICAL INC | $ 268.74M |
| VEEV : VEEVA SYSTEMS INC | $ 941.65M |
| SRPT : SAREPTA THERAPEUTICS INC | $ 65.06M |
| FTRE : FORTREA HOLDINGS INC | $ -446.9M |
| RVMD : REVOLUTION MEDICINES INC | $ -1.37B |
Similar metrics to Net Inc. Cmn.:
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Net Income - [Income Statement] Net income is the accounting profit or loss a business generated after covering all of its costs, before deduction of preferred stock dividends [PrefDivIS].
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
Definition of Net Income Common Stock
[Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
RPRX - Net Income Common Stock, Last 5 years
$ 42.83M
Minimum
Dec 31, 2022
$ 1.15B
Maximum
Sep 30, 2024
$ 692.55M
Average
$ 767.95M
Median
Net Inc. Cmn. Benchmark AnalysisMarket
The chart above depicts the distribution of Net Inc. Cmn. for companies in the Total Stock Market. The average Net Inc. Cmn. of the companies is $ 14.7M with a standard deviation of $ 128.41M.
The following table provides additional summary stats:
Net Inc. Cmn. in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | $ -397.69M |
| max | $ 412.5M |
| average | $ 14.7M |
| median | $ -587K |
| std | $ 128.41M |